Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Japanese Drug Makers Are Innovative But Regulations Are a Problem: Prof.Kneller at JPLA Seminar
March 10, 2003
- Detailed Rules for CRC Certification Announced by JSCPT
March 10, 2003
- PHARMA NETWORK Codevelops MR Evaluation System
March 10, 2003
- Korosho to Use Electronized Data to Optimize Nursing Care Benefits
March 10, 2003
- BUSINESS NEWS IN BRIEF
March 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 10, 2003
- WEBSITE NEWS
March 10, 2003
- Fujisawa Updates R&D Pipeline
March 10, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
March 10, 2003
- PRESS SEMINAR
March 10, 2003
- Gov't Allows Private Companies to Operate Medical Institutions
March 10, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 10, 2003
- Schedule for Changes in Approval Procedures Outlined
March 10, 2003
- Toyama Transfers OTC Products to Taisho, Kyorin
March 10, 2003
- PFSB Taking Public Comments on Amended PAL Ordinances
March 10, 2003
- JACDS Drafting GLs for Introduction of Category Management
March 10, 2003
- JMA to Stress Need for Higher Price Adjustment Zone
March 10, 2003
- OTC NEWS IN BRIEF
March 10, 2003
- Package Insert Revisions for Edaravone Required: Safety Info
March 10, 2003
- DIAGNOSTIC NEWS IN BRIEF
March 10, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…